Cancer in HIV-positive and HIV-negative adolescents and young adults in South Africa: a cross-sectional study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 10 2021
Historique:
entrez: 19 10 2021
pubmed: 20 10 2021
medline: 3 11 2021
Statut: epublish

Résumé

To determine the spectrum of cancers in adolescents and young adults (AYAs) living with and without HIV in South Africa. Cross-sectional study with cancer records provided by the National Cancer Registry (NCR) and HIV records from the National Health Laboratory Service (NHLS). The NHLS is the largest provider of pathology services in the South African public sector. The NCR is a division of the NHLS. We included AYAs (aged 10-24 years) diagnosed with cancer by public health sector laboratories between 2004 and 2014 (n=8479). HIV status was obtained through record linkages and text mining. We determined the spectrum of cancers by HIV status in AYAs. We used multivariable logistic regression to describe the association of cancer in AYAs with HIV, adjusting for age, sex, ethnicity and calendar period. We imputed (post hoc) the HIV status for AYA with unknown HIV status. 8479 AYAs were diagnosed with cancer, HIV status was known for 45% (n=3812). Of those whose status was known, about half were HIV positive (n=1853). AYAs living with HIV were more likely to have Kaposi's sarcoma (adjusted OR (aOR) 218, 95% CI 89.9 to 530), cervical cancer (aOR 2.18, 95% CI 1.23 to 3.89), non-Hodgkin's lymphoma (aOR 2.12, 95% CI 1.69 to 2.66) and anogenital cancers other than cervix (aOR 2.73, 95% CI 1.27 to 5.86) than AYAs without HIV. About 44% (n=1062) of AYAs with HIV-related cancers had not been tested for HIV. Targeted HIV testing for AYAs diagnosed with cancer, followed by immediate start of antiretroviral therapy, screening for cervical precancer and vaccination against human papilloma virus is needed to decrease cancer burden in AYAs living with HIV in South Africa.

Identifiants

pubmed: 34663647
pii: bmjopen-2020-043941
doi: 10.1136/bmjopen-2020-043941
pmc: PMC8524277
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e043941

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI069924
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

South Afr J HIV Med. 2018 Nov 26;19(1):826
pubmed: 30568836
J Int AIDS Soc. 2019 Jun;22(6):e25326
pubmed: 31243898
Clin Infect Dis. 2016 Nov 1;63(9):1245-1253
pubmed: 27578823
Lancet HIV. 2019 Nov;6(11):e760-e768
pubmed: 31585836
Int J Cancer. 2014 Dec 1;135(11):2644-52
pubmed: 24729433
Immunol Res. 2010 Dec;48(1-3):72-83
pubmed: 20717742
BMJ Glob Health. 2016 Oct 24;1(3):e000004
pubmed: 28588949
BMJ Open. 2018 Aug 23;8(8):e021506
pubmed: 30139898
J Int AIDS Soc. 2017 May 16;20(Suppl 3):21668
pubmed: 28530037
J Med Virol. 2016 Nov;88(11):1944-52
pubmed: 27096166
PLoS One. 2015 Aug 12;10(8):e0135602
pubmed: 26267867
Pediatr Infect Dis J. 2016 Jun;35(6):e164-70
pubmed: 26906162
Infect Dis Obstet Gynecol. 2014;2014:498048
pubmed: 25389377
Curr Opin HIV AIDS. 2018 May;13(3):196-203
pubmed: 29461329
S Afr Med J. 2012 Nov 02;103(1):32-3
pubmed: 23237121
Cancer Lett. 2014 May 28;347(1):38-45
pubmed: 24513180
PLoS One. 2012;7(9):e45507
pubmed: 23029060
Int J Cancer. 2017 Aug 1;141(3):488-496
pubmed: 28440019
Int J Cancer. 2015 Jun 1;136(11):2628-39
pubmed: 25363616
Ann Intern Med. 2010 Oct 5;153(7):452-60
pubmed: 20921544
Infect Agent Cancer. 2019 May 3;14:12
pubmed: 31073325
Clin Infect Dis. 2014 Jun;58(11):1599-606
pubmed: 24523217
Clin Infect Dis. 2017 Mar 15;64(6):818-819
pubmed: 28077522
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):148-54
pubmed: 22068287
S Afr Med J. 2015 Apr;105(4):304-7
pubmed: 26294851
South Afr J HIV Med. 2017 Sep 29;18(1):731
pubmed: 29568638

Auteurs

Tafadzwa Dhokotera (T)

National Cancer Registry, National Health Laboratory Service, Johannesburg, Gauteng, South Africa tafadzwagladys.dhokotera@swisstph.ch.
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
Division of Epidemiology and Biostatistics, University of the Witwatersrand School of Public Health, Johannesburg, South Africa.

Julia Bohlius (J)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Matthias Egger (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Centre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town School of Public Health and Family Medicine, Observatory, Western Cape, South Africa.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Adrian Spoerri (A)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Jabulani Ronnie Ncayiyana (JR)

Division of Epidemiology and Biostatistics, University of the Witwatersrand School of Public Health, Johannesburg, South Africa.
Centre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town School of Public Health and Family Medicine, Observatory, Western Cape, South Africa.

Gita Naidu (G)

Paediatric Haematology Oncology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg-Braamfontein, Gauteng, South Africa.

Victor Olago (V)

National Cancer Registry, National Health Laboratory Service, Johannesburg, Gauteng, South Africa.
Division of Epidemiology and Biostatistics, University of the Witwatersrand School of Public Health, Johannesburg, South Africa.

Marcel Zwahlen (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Elvira Singh (E)

National Cancer Registry, National Health Laboratory Service, Johannesburg, Gauteng, South Africa.
Division of Epidemiology and Biostatistics, University of the Witwatersrand School of Public Health, Johannesburg, South Africa.

Mazvita Muchengeti (M)

National Cancer Registry, National Health Laboratory Service, Johannesburg, Gauteng, South Africa.
Division of Epidemiology and Biostatistics, University of the Witwatersrand School of Public Health, Johannesburg, South Africa.
South African DSI-NRF Centre for Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH